Artemisinin-polypyrrole conjugates: synthesis, DNA binding studies and preliminary antiproliferative evaluation.

Louise LaPensée, Sunil Sabbani, Raman Sharma, Inder Bhamra, Emma Shore, Amy E. Chadwick, Neil G. Berry, James Firman, Nuna C. Araujo, Lília Cabral, Maria L.S. Cristiano, Cerys Bateman, Omar Janneh, Adelina Gavrila, Yi Hang Wu, Afthab Hussain, Steve Ward, Paul A. Stocks, Rick Cosstick, Paul M. O'Neill

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

Greater than the sum of its parts: Artemisinins are currently in phase I-II clinical trials against breast, colorectal and non-small-cell lung cancers. In an attempt to offer increased specificity, a series of hybrid artemisinin-polypyrrole minor groove binder conjugates are described. DNA binding/modelling studies and preliminary biological evaluation give insights into their mechanism of action and the potential of this strategy.

Original languageEnglish
Pages (from-to)709-718
Number of pages10
JournalChemMedChem
Volume8
Issue number5
DOIs
Publication statusPublished - 1 May 2013

Keywords

  • Artemisinin
  • Binding studies
  • Cytotoxicity
  • DNA
  • Molecular modelling

Fingerprint

Dive into the research topics of 'Artemisinin-polypyrrole conjugates: synthesis, DNA binding studies and preliminary antiproliferative evaluation.'. Together they form a unique fingerprint.

Cite this